CANCER BIOMARKERS
The present invention relates to a method of prognosis for renal cell carcinoma in a subject, said method comprising determining the level and/or chemical composition of one or both of the glycosaminoglycans (GAGs) chondroitin sulfate (CS) and heparan sulfate (HS) in a body fluid sample, wherein sai...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
23.10.2018
|
Subjects | |
Online Access | Get full text |
Cover
Summary: | The present invention relates to a method of prognosis for renal cell carcinoma in a subject, said method comprising determining the level and/or chemical composition of one or both of the glycosaminoglycans (GAGs) chondroitin sulfate (CS) and heparan sulfate (HS) in a body fluid sample, wherein said sample has been obtained from said subject.
本发明涉及种受试者中肾细胞癌的预测方法,所述方法包括测定体液样品中种或两种糖胺聚糖(GAG)硫酸软骨素(CS)和硫酸乙酰肝素(HS)的水平和/或化学组成,其中所述样品已从所述受试者获得。 |
---|---|
Bibliography: | Application Number: CN201780009605 |